Regulation of RhoA activity

No Pathway Network information available for Regulation of RhoA activity

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with Regulation of RhoA activity SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Martsolf syndrome 1EnrichmentARHGAP35, ARHGAP53.93
2Nephrotic syndrome, type 8EnrichmentARHGDIA2.46
3Immunodeficiency 62EnrichmentARHGEF12.46
4Immunodeficiency 87 and autoimmunityEnrichmentDEF62.46
5Neurodevelopmental disorder with midbrain and hindbrain malformationsEnrichmentARHGEF22.46
6Retinitis pigmentosa 78EnrichmentARHGEF182.46
7Intellectual developmental disorder, x-linked, syndromic, billuart typeEnrichmentOPHN12.46
8Slowed nerve conduction velocity, autosomal dominantEnrichmentARHGEF102.46
9Celiac disease 4EnrichmentMYO9B2.46
10Neuroendocrine tumorEnrichmentCDKN1B2.46
11Brain small vessel disease 5 with osteoporosisEnrichmentARHGEF152.46
12Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomaliesEnrichmentRHOA2.46
13Alfadhel syndromeEnrichmentRAP1GDS12.46
14Intellectual developmental disorder, autosomal dominant 63, with macrocephalyEnrichmentTRIO2.46
15Linear hypopigmentation and craniofacial asymmetry with acral, ocular and brain anomaliesEnrichmentRHOA2.46
16Deafness, autosomal recessive 28EnrichmentTRIO2.16
17Multiple endocrine neoplasia, type ivEnrichmentCDKN1B2.16
18Spastic paraplegia 70, autosomal recessiveEnrichmentARHGAP92.16
19Chromosome 8p11 myeloproliferative syndromeEnrichmentBCR1.98
20Intellectual developmental disorder, autosomal dominant 44, with microcephalyEnrichmentTRIO1.98
21Chromosome 22q11.2 deletion syndrome, distalEnrichmentBCR1.86
22OligohydramniosEnrichmentOPHN11.86
23Primary hyperparathyroidismEnrichmentCDKN1B1.86
24Hemihyperplasia, isolatedEnrichmentRHOA1.69
25Anterior segment dysgenesis 5EnrichmentARHGAP351.69
26Multiple endocrine neoplasia, type iEnrichmentCDKN1B1.62
27Thyroid cancer, nonmedullary, 2EnrichmentSRGAP11.62
28Leukemia, chronic myeloidEnrichmentBCR1.62
29Follicular thyroid carcinomaEnrichmentSRGAP11.62
30Moyamoya angiopathyEnrichmentARHGEF251.62
31B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)EnrichmentBCR1.62
32Peters-plus syndromeEnrichmentARHGAP351.47
33Amelogenesis imperfecta, type ieEnrichmentARHGAP61.47
34Neural tube defectsEnrichmentDLC11.36
35Amelogenesis imperfectaEnrichmentARHGAP61.36
36Syndromic intellectual disabilityEnrichmentTRIO1.24
37Precursor t-cell acute lymphoblastic leukemiaEnrichmentBCR1.11
38CakutEnrichmentSRGAP10.95
39Genetic steroid-resistant nephrotic syndromeEnrichmentARHGDIA0.95
40Developmental and epileptic encephalopathyEnrichmentARHGEF150.93
41Charcot-marie-tooth diseaseEnrichmentARHGEF100.88
42Colorectal cancerEnrichmentDLC10.58
43Ovarian cancerEnrichmentCDKN1B0.53
44Congenital nervous system abnormalityEnrichmentOPHN10.51
45Nervous system diseaseEnrichmentOPHN10.51
46MicrocephalyEnrichmentTRIO0.46
47Inherited cancer-predisposing syndromeEnrichmentCDKN1B0.43
48Retinitis pigmentosaEnrichmentARHGEF180.28
49Hereditary retinal dystrophyEnrichmentARHGEF180.19
50Fundus dystrophyEnrichmentARHGEF180.19

Loading...
Loading...
Loading...